EUOS Journal Club 24/25 Meeting 1

Name: EUOS Journal Club 24/25 Meeting 1
Start: 2024-10-10T18:00:00+00:00
End: 2024-10-10T19:00:00+00:00

10th Oct 2024

7:00 - 8:00pm (BST)

Clinical oncology

Medical oncology

10th Oct 2024

7:00 - 8:00pm (BST)

Link not provided

Attendance certificate available

This event has ended. Similar events

Free

Description

Join us for our first EUOS Journal Club on 10th October (Thursday) from 7-8pm!

We will hear from Revathi who will present the paper 'Relatlimab and Nivolumab versus Nivolumab in Untreated Advanced Melanoma' (link: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9844513/). Following the presentation, there will also be an interactive discussion for participants to practise critically appraising a paper.

Join Zoom Meeting

https://ed-ac-uk.zoom.us/j/86909639148

Meeting ID: 869 0963 9148

Passcode: gy0mR3uh

✨️ See you there!

Summary

Join us for the inaugural EUOS Journal Club meeting on October 10th! Revathi will present a thought-provoking session on 'Relatlimab and Nivolumab versus Nivolumab in Untreated Advanced Melanoma.' This will be followed by an interactive discussion enabling participants to hone their critical appraisal skills. Participate in this engaging and interactive Zoom session to deepen your knowledge about untreated advanced melanoma. Don't miss out!

Generated by MedBot

Learning objectives

To understand and evaluate the comparative study of the efficacy of Relatlimab and Nivolumab versus Nivolumab alone in treating advanced melanoma as presented in the chosen paper.
Develop the ability to critically assess medical research papers, focusing on methodology, data interpretation, and potential biases.
Enhance comprehension of clinical trials and their implications in the management of melanoma and other similar conditions.
Gain insight into the latest advancements in melanoma treatment and how they can be applied in current practice.
Facilitate a constructive discussion and exchange of opinions among peers to improve understanding and application of the research findings.

Generated by MedBot

6 people attended this event. Sign up today and join your colleagues at future events.

View all